Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9

Cancer Letters

Volumn 289, Issue 1, 2010, Pages 53-61

  Kenig, Saša ^a   Alonso, María Beatriz Durán ^a   Mueller, Margareta M ^b   Lah, Tamara T ^a  

^a NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenesis; Chemokines (CXCL12 SDF 1); Cysteine cathepsins; Glioblastoma invasion; Matrix metalloproteases

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; CYSTATIN C; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE; STEFIN A; STEFIN B; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VASCULARIZATION;

BASE SEQUENCE; CATHEPSIN B; CATHEPSINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; PROTEASE INHIBITORS; UP-REGULATION;

EID: 75949130595     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.07.014     Document Type: Article

References (53)

1. Ohgaki H., and Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathpl. 109 (2005) 93-108
2. Sathornsumetee S., and Rich J.N. New treatment strategies for malignant gliomas. Expert Rev. Anticancer Ther. 6 (2006) 1087-1104
3. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
4. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
5. Bergers G., and Benjamin L.E. Tumourigenesis and the angiogenic switch. Nat. Rev. Cancer 3 (2003) 401-410
6. von Bulow C., Hayen W., Hartmann A., Mueller-Klieser W., Allolio B., and Nehls V. Endothelial capillaries chemotactically attract tumour cells. J. Pathol. 193 (2001) 367-376
7. Lah T.T., Duran Alonso M.B., and Van Noorden C.J. Antiprotease therapy in cancer: hot or not?. Expert Opin. Biol. Ther. 6 (2006) 257-279
8. Friedl P., and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3/5 (2003) 362-374
9. Tu C., Ortega-Cava C.F., Chen G., Fernandes N.D., Cavallo-Medved D., Sloane B.F., Band V., and Band H. Lysosomal cathepsins B participates in the podosome-mediated extracellular matrix degradation and invasion vi secreted lysosomes in the v-Src fibroblasts. Cancer Res. 86/22 (2008) 9147-9156
10. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3 (2003) 489-501
11. Levičar N., Nuttall R.K., and Lah T.T. Proteases in brain tumour progression. Acta Neurochir. (Wien.) 145 (2003) 825-838
12. Strojnik T., Zajc I., Bervar A., Zidanik B., Golouh R., Kos J., Dolenc V., and Lah T. Cathepsin B and its inhibitor stefin A in brain tumours. Pflugers Arch. 439 (2000) R122-R123
13. Strojnik T., Kos J., Zidanik B., and Lah T. Cathepsin B immunohistochemical staining in tumour, endothelial cells is a new prognostic factor for survival in patients with brain tumours. Clin. Cancer Rest. 5 (1999) 559-567
14. Sivaparvathi M., Sawaya R., Wang S.W., Rayford A., Yamamoto M., Liotta L.A., Nicolson G.L., and Rao J.S. Overexpression and localization of cathepsin B during the progression of human gliomas. Clin. Exp. Metast. 13 (1995) 49-56
15. Mikkelsen T., Yan P.S., Ho K.L., Sameni M., Sloane B.F., and Rosenblum M.L. Immunolocalization of cathepsin B in human glioma: implications for tumour invasion and angiogenesis. J. Neurosurg. 83 (1995) 285-289
16. Sameni M., Dosescu J., and Sloane B.F. Imaging proteolysis by living human glioma cells. Biol. Chem. 382 (2001) 785-788
17. Lakka S.S., Gondi C.S., Yanamandra N., Olivero W.C., Dinh D.H., Gujrati M., and Rao J.S. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumour cell invasion, tumour growth and angiogenesis. Oncogene 23 (2004) 4681-4689
18. Premzl A., Turk V., and Kos J. Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro. J. Cell Biochem. 97 (2006) 1230-1240
19. Kondraganti S., Mohanam S., Chintala S.K., Kin Y., Jasti S.L., Nirmala C., Lakka S.S., Adachi Y., Kyritsis A.P., Ali-Osman F., Sawaya R., Fuller G.N., and Rao J.S. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Rest. 60 (2000) 6851-6855
20. Goldbrunner R.H., Bernstein J.J., and Tonn J.C. Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir. (Wien.) 141 (1999) 295-305 discussion 304-305
21. Tews D.S., and Nissen A. Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumours. Invas. Metast. 18 (1998) 271-284
22. Rosenman S.J., Shrikant P., Dubb L., Benveniste E.N., and Ransohoff R.M. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154 (1995) 1888-1899
23. Mueller M.M., Werbowetski T., and Del Maestro R.F. Soluble factors involved in glioma invasion. Acta Neurochir. (Wien.) 145 (2003) 999-1008
24. Mueller M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4 (2004) 839-849
25. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4 (2004) 540-550
26. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumour cells and their microenvironment. Blood 107 (2006) 1761-1767
27. Albini A., and Sporn M.B. The tumour microenvirnment as a target for chemoprevetion. Nat. Rev. Cancer 7 (2007) 139-147
28. Kos J., and Lah T.T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol. Rep. 5 (1998) 1349-1361
29. Jedeszko C., and Sloane B.F. Cysteine cathepsins in human cancer. Biol. Chem. 385 (2004) 1017-1027
30. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
31. Masson V., de la Ballina L.R., Munaut C., Wielockx B., Jost M., Maillard C., Blacher S., Bajou K., Itoh T., Itohara S., Werb Z., Libert C., Foidart J.M., and Noel A. Contribution of host MMP-2 and MMP-9 to promote tumour vascularization and invasion of malignant keratinocytes. FASEB J. 19 (2005) 234-236
32. Park C.M., Park M.J., Kwak H.J., Lee H.C., Kim M.S., Lee S.H., Park I.C., Rhee C.H., and Hong S.I. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Rest. 66 (2006) 8511-8519
33. Strojnik T., Kavalar R., Trinkaus M., and Lah T.T. Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect. Prev. 29 (2005) 448-455
34. Zajc I., Hreljac I., and Lah T. Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics. Anticancer Rest. 26 (2006) 3357-3364
35. Flannery T., Gibson D., Mirakhur M., McQuaid S., Greenan C., Trimble A., Walker B., McCormick D., and Johnston P.G. The clinical significance of cathepsin S expression in human astrocytomas. Am. J. Pathol. 163 (2003) 175-182
36. Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y., Greenbaum D.C., Hager J.H., Bogyo M., and Hanahan D. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumourigenesis. Cancer Cell 5 (2004) 443-453
37. Khodarev N.N., Yu J., Labay E., Darga T., Brown C.K., Mauceri H.J., Yassari R., Gupta N., and Weichselbaum R.R. Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J. Cell Sci. 116 (2003) 1013-1022
38. Charalambous C., Virrey J., Kardosh A., Jabbour M.N., Qazi-Abdullah L., Pen L., Zidovetzki R., Schonthal A.H., Chen T.C., and Hofman F.M. Glioma-associated endothelial cells show evidence of replicative senescence. Exp. Cell Rest. 313 (2007) 1192-1202
39. Yanamandra N., Gumidyala K.V., Waldron K.G., Gujrati M., Olivero W.C., Dinh D.H., Rao J.S., and Mohanam S. Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene 23 (2004) 2224-2230
40. Scala S., Ottaiano A., Ascierto P.A., Cavalli M., Simeone E., Giuliano P., Napolitano M., Franco R., Botti G., and Castello G. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin. Cancer Rest. 11 (2005) 1835-1841
41. Wang B., Sun J., Kitamoto S., Yang M., Grubb A., Chapman H.A., Kalluri R., and Shi G.P. Cathepsin S controls angiogenesis and tumour growth via matrix-derived angiogenic factors. J. Biol. Chem. 281 (2006) 6020-6029
42. Zeelenberg I.S., Ruuls-Van Stalle L., and Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Rest. 63 (2003) 3833-3839
43. Scotton C.J., Wilson J.L., Scott K., Stamp G., Wilbanks G.D., Fricker S., Bridger G., and Balkwill F.R. Multiple actions of the chemokine CXCL12 on epithelial tumour cells in human ovarian cancer. Cancer Rest. 62 (2002) 5930-5938
44. Hong X., Jiang F., Kalkanis S.N., Zhang Z.G., Zhang X.P., DeCarvalho A.C., Katakowski M., Bobbitt K., Mikkelsen T., and Chopp M. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 236 (2006) 39-45
45. Zhang J., Sarkar S., and Yong V.W. The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26 (2005) 2069-2077
46. Yang S.X., Chen J.H., Jiang X.F., Wang Q.L., Chen Z.Q., Zhao W., Feng Y.H., Xin R., Shi J.Q., and Bian X.W. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem. Biophys. Rest. Commun. 335 (2005) 523-528
47. Yuecheng Y., and Xiaoyan X. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2. Eur. J. Cancer Prev. 16 (2007) 430-435
48. Tang C.H., Tan T.W., Fu W.M., and Yang .S. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 29 (2008) 35-43
49. McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., and Overall C.M. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276 (2001) 43503-43508
50. Salmaggi A., Gelati M., Pollo B., Frigerio S., Eoli M., Silvani A., Broggi G., Ciusani E., Croci D., Boiardi A., and De Rossi M. CXCL12 in malignant glial tumours: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J. Neuro-Oncol. 67 (2004) 305-317
51. Zagzag D., Esancay M., Mendez O., Yee H., Smirnova I., Huang Y., Chiribon L., Lukyanov E., Liu M., and Newcomb E. Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am. J. Pathol. 173 (2008) 545-560
52. Bergers G., Brekken R., McMahon G.M., Vu H.T., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., and Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogensis. Nat. Cell Biol. 2 (2000) 737-744
53. Parmo-Cabanas M., Molina-Ortiz I., Matias-Roman S., Garcia-Bernal D., Carvajal-Vergara X., Valle I., Pandiella A., Arroyo A.G., and Teixido J. Role of metaloproteinases MMP9 and MT1-MMP in CXCL2-promoted myleoma cell invasion across basement membranes. J. Pathol. 208 (2006) 108-118